Related Experiment Video
Updated: Feb 8, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an
Steven K Jones1, Kirk Douglas2, Anthony F Shields2
1Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Abstract:
Using an orthotopic model of ovarian cancer, we studied the delivery of siRNA in nanoparticles of tri-block copolymers consisting of hyperbranched polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) (hyPEI-g-PCL-b-PEG) with and without a folic acid targeting ligand. A SKOV-3/LUC FRα overexpressing cell line was employed to mimic the clinical manifestations of ovarian cancer. Both targeted and non-targeted micelleplexes were able to effectively deliver siRNA to the primary tumor and its metastases, as measured by gamma scintillation counting and confocal microscopy. Stability of the micelleplexes was demonstrated with a serum albumin binding study. Regarding biodistribution, intravenous (I.V.) administration showed a slight advantage of FRα targeted over non-targeted micelleplex accumulation within the tumor. However, both formulations displayed significant liver uptake. On the other hand, intraperitoneally (I.P.) injected mice showed a modest 6% of the injected dose per gram (ID/g) uptake within the primary and most interestingly also in the metastatic lesions which subsequently resulted in a 62% knockdown of firefly luciferase expression in the tumor after a single injection. While this is, to the best of our knowledge, the first paper that correlates quantitative tumor accumulation in an orthotopic tumor model with in vivo gene silencing, these data demonstrate that PEI-g-PCL-b-PEG-Fol conjugates are a promising option for gene knockdown in ovarian cancer.
Insights
Targeted nanoparticles effectively delivered siRNA to ovarian tumors and metastases, achieving significant gene knockdown. Intraperitoneal injection showed promising tumor accumulation and gene silencing, highlighting potential for ovarian cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Ovarian cancer presents significant treatment challenges.
- Effective delivery of small interfering RNA (siRNA) is crucial for gene silencing therapies.
- Targeted nanoparticle delivery systems can improve therapeutic efficacy.
Purpose of the Study:
- To evaluate the efficacy of novel tri-block copolymer nanoparticles for siRNA delivery in an orthotopic ovarian cancer model.
- To compare targeted (folic acid ligand) versus non-targeted nanoparticles.
- To correlate nanoparticle tumor accumulation with in vivo gene silencing.
Main Methods:
- Development of hyperbranched polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) (hyPEI-g-PCL-b-PEG) nanoparticles, with and without folic acid.
- Utilized an orthotopic SKOV-3/LUC FRα-overexpressing ovarian cancer model in mice.
- Assessed siRNA delivery and tumor accumulation using gamma scintillation counting and confocal microscopy.
- Quantified gene silencing via firefly luciferase expression knockdown.
Main Results:
- Both targeted and non-targeted nanoparticles effectively delivered siRNA to primary tumors and metastases.
- Intraperitoneal (I.P.) administration resulted in significant tumor uptake (6% ID/g) and a 62% knockdown of luciferase expression.
- Intravenous (I.V.) administration showed a slight advantage for targeted nanoparticles in tumor accumulation, but both had high liver uptake.
- Nanoparticle stability was confirmed via serum albumin binding studies.
Conclusions:
- PEI-g-PCL-b-PEG-Fol conjugates demonstrate potential as a promising platform for ovarian cancer gene knockdown therapy.
- Intraperitoneal delivery of these targeted nanoparticles is effective for achieving significant gene silencing in both primary and metastatic ovarian tumors.
- Further research is warranted to optimize delivery and minimize off-target effects like liver accumulation.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Correlations
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

